|
02 Oct 2007 |
FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use
|
|
02 Oct 2007 |
BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer
|
|
02 Oct 2007 |
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
|
|
28 Sep 2007 |
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
|
|
28 Sep 2007 |
Nuvelo Announces Publication of NU206 Study Results in Proceedings of the National Academy of Sciences of the United States of America
|
|
28 Sep 2007 |
Palatin Technologies, Inc. Reports positive data from an at-home study of pre- and postmenopausal women with female sexual arousal disorder treated with bremelanotide
|
|
27 Sep 2007 |
Nycomed and NPS Pharmaceuticals Announce Licensing Agreement for GATTEX(TM)
|
|
27 Sep 2007 |
Phase 2 Study Suggests That Extended Dosing of Aranesp(R) is as Efficacious as Weekly Dosing
|
|
27 Sep 2007 |
Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
|
|
27 Sep 2007 |
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
|
|
27 Sep 2007 |
Cytheris Expands Interleukin-7 Clinical Development Program With International Phase I/IIa Trial In HIV
|
|
27 Sep 2007 |
New Analysis Suggests First Cycle Use of Neulasta(R) Reduces Febrile Neutropenia Hospitalizations and Chemotherapy Dose Reductions in Breast Cancer Patients Compared to Current Practice
|
|
27 Sep 2007 |
OctoPlus in-licenses diabetes product candidate
|
|
25 Sep 2007 |
Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
|
|
25 Sep 2007 |
European Union's CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
|
|
25 Sep 2007 |
Pacgen Announces Advances in PAC-113 Program
|
|
22 Sep 2007 |
ThromboGenics Completes Enrolment of Patients for the Vitreomacular Traction Trial (MIVI IIT)
|
|
22 Sep 2007 |
Maxygen Announces Hold on MAXY-alpha Development Program
|
|
22 Sep 2007 |
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
|
|
21 Sep 2007 |
Acceleron Pharma's ACE-011 Increases Bone Mineral Density and Bone Strength in Primate Studies
|
|
21 Sep 2007 |
Novo Nordisk receives approval in the EU for use of NovoRapid(R) in elderly people
|
|
20 Sep 2007 |
Zelos Therapeutics Presents Positive Data at ASBMR on Subcutaneous and Inhaled Delivery of Cyclic PTH (1-31) (Ostabolin-C(TM))
|
|
20 Sep 2007 |
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
|
|
19 Sep 2007 |
New Data Support Long-Term Efficacy and Safety in Patients Who Took Exubera for Eight Years
|
|
19 Sep 2007 |
Sinobiomed Updates on Clincial Trial Success for Recombinant Batroxobin (rBat)
|
